Intuitive Surgical Inc. (ISRG)

NASDAQ: ISRG · USD

$379

+5.08 (+1.4%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-08-10 02:00 UTC. Latest published research analyzed 2026-05-09 · historical · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh ISRG analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-09

Our latest published analysis: ISRG rated Sell

Sell. Exceptional business quality is entirely overshadowed by extreme overvaluation.

Fair value (mid)

$255 / share

$176 – $337

Upside to FV

-43.4%

from $379

Confidence

87/100

Moat

9/10

Read full analysis

Market cap	$159.4B
Revenue (ttm)	11B
Net income (ttm)	3.1B
EPS (ttm)	$8.72
Shares out	353.3M
P/E (trailing)	43.4x
P/E (forward)	38.2x
Volume	2,465,651
Beta	1.46
Price target	$477	+26.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11B
Net income (ttm): 3.1B
EPS (ttm): $8.72
P/E (trailing): 43.4x
P/E (forward): 38.2x
Market cap: $159.4B

Item	P1	P2	P3	P4	Trend
Period	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$6.22B	$7.12B	$8.35B	$10.06B	+17.4%
Gross profit	$4.20B	$4.73B	$5.63B	$6.64B	+16.5%
Operating income	$1.58B	$1.77B	$2.35B	$2.95B	+23.1%
Net income	—	—	—	—	—
EPS (diluted)	$3.65	$5.03	$6.42	$7.87	+29.2%
EBITDA	$1.94B	$2.22B	$2.85B	$3.62B	+23.1%
R&D	$879.0M	$998.8M	$1.15B	$1.31B	+14.3%
SG&A	$1.74B	$1.96B	$2.14B	$2.39B	+11.1%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.6T	35.9x	9.8x	101.6%	+6.1%	+35.1%	Sell
ABNB	Airbnb Inc.	108.9B	41.8x	8.3x	16.8%	+24.4%	+52.6%	Hold
ADBE	Adobe Inc.	108.5B	15.6x	4.3x	60.7%	+11.9%	-20.0%	Strong Buy
ABBV	AbbVie Inc.	438.2B	70.1x	6.8x	17.7%	+3.7%	+29.1%	Hold
ABT	Abbott Laboratories	188B	35.1x	4.0x	7.5%	+3.0%	-17.2%	Strong Buy
AMGN	Amgen Inc.	225.6B	25.9x	5.9x	19.8%	+8.4%	+49.1%	Strong Buy

All ISRG indicators

Market & fundamental data

Available fields

281

Groups with data

Currency

USD

Showing 281 of 281 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001035267
Company name	Intuitive Surgical, Inc.
Country	United States
Country code	US
Cusip	46120E602
Employees	17,021
Employees Change	1,383%
Employees Change Percent	8.84
Enterprise value	$128.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500, NASDAQ100
Industry	Medical Instruments & Supplies
Industry PE	72.83
Industry PE Fwd	21.9
IPO Date	2000-06-13
Isin	US46120E6023
Last refreshed	2026-08-10
Market cap	$133.8B
Market cap category	Large-Cap
Price	$379
Price currency	USD
Rev Per Employee	648,281.53x
Sector	Healthcare
Sector PE	49.71
Sector PE Fwd	22.47
Sic	3842
Symbol	ISRG
Tags	artificial-intelligence, robotics
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.35%
EV Earnings	40.97x
EV Sales Forward	10.32x
EV/EBIT	37.27x
EV/EBITDA	30.29x
EV/FCF	39.91x
EV/Sales	11.66x
FCF yield	2.41%
Forward P/E	33.53x
P/B ratio	7.38x
P/E ratio	43.44x
P/S ratio	12.13x
PE Ratio10 Y	61.81x
PE Ratio3 Y	67.75x
PE Ratio5 Y	67.31x
PEG ratio	2.13x
PS Forward	10.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.28%
EBITDA Margin	38.47%
FCF margin	29.21%
Gross margin	66.68%
Gross Profit	$7.4B
Gross Profit Growth	20.78%
Gross Profit Growth Q	21.17%
Gross Profit Growth3 Y	18.27%
Gross Profit Growth5 Y	15.72%
Net Income	$3.1B
Net Income Growth	20.37%
Net Income Growth Q	24.26%
Net Income Growth Quarters	13%
Net Income Growth Years	3%
Net Income Growth3 Y	30.11%
Net Income Growth5 Y	14.11%
Pretax Margin	34.49%
Profit Margin	28.45%
Profit Per Employee	$184,407
Profitable Quarters	$34
Profitable Years	22
ROA	10.51
Roa5y	8.5
ROCE	18.21
ROE	17.42
Roe5y	14.94
ROIC	21.89
Roic5y	21.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.27%
Cagr15y	16.2%
Cagr1y	-20.1%
Cagr20y	19.33%
Cagr3y	6.99%
Cagr5y	1.99%
EPS Growth	21.65
EPS Growth Q	26.52
EPS Growth Quarters	13
EPS Growth Years	3
EPS Growth3 Y	29.79
EPS Growth5 Y	14.33
FCF Growth	61.59%
FCF Growth Q	69.33%
FCF Growth3 Y	39.88%
FCF Growth5 Y	14.16%
OCF Growth	31.15%
OCF Growth Q	48.31%
OCF Growth10 Y	14.56%
OCF Growth3 Y	25.88%
OCF Growth5 Y	14.03%
Revenue Growth	20.66x
Revenue Growth Q	18.54x
Revenue Growth Quarters	23x
Revenue Growth Years	5x
Revenue Growth3 Y	18.3x
Revenue Growth5 Y	16.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$20.9B
Cash	$5.2B
Current Assets	$9.5B
Current Liabilities	$1.9B
Debt	$0
Debt EBITDA	$0
Equity	$18.3B
Liabilities	$2.6B
Long Term Assets	$11.3B
Long Term Liabilities	$656M
Net Cash	$5.2B
Net Cash By Market Cap	$3.9
Net Cash Growth	-2.07%
Net Debt EBITDA	$-1.23
Net Debt Equity	$-0.29
Net Debt FCF	$-1.62
Tangible Book Value	$17.4B
Tangible Book Value Per Share	$49.14
WACC	12.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.96
Inventory Turnover	1.99
Net Working Capital	$2.4B
Quick ratio	3.64
Working Capital	$7.6B
Working Capital Turnover	$1.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	391.73%
1Y total return	-20.09%
200-day SMA	480.2
3Y total return	22.47%
50-day SMA	393.2
50-day SMA vs 200-day SMA	50under200
5Y total return	10.33%
All Time High	616
All Time High Change	-38.5%
All Time High Date	2025-01-23
All Time Low	0.67
All Time Low Change	56,718.66%
All Time Low Date	2001-04-03
ATR	13.56
Beta	1.46
Beta1y	1.01
Beta2y	1.15
Ch YTD	-33.11
High	379.9
High52	603.9
High52 Date	2026-01-07
High52ch	-37.27%
Low	372.6
Low52	328.6
Low52 Date	2026-07-23
Low52ch	15.29%
Ma50ch	-3.65%
Premarket Change Percent	0.21
Premarket Price	$374
Premarket Volume	2,516
Price vs 200-day SMA	-21.11%
RSI	51.32
RSI Monthly	40.91
RSI Weekly	37.32
Sharpe ratio	-0.55x
Sortino ratio	-0.61
Total Return	1.11%
Tr YTD	-33.11
Tr15y	850.8%
Tr1m	-12.48%
Tr1w	7.21%
Tr3m	-16.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	33
Analyst Count Top	8
Analyst Price Target Top	$460
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$2.41
Earnings EPS Estimate Growth	10.05
Earnings Revenue Estimate	2,821,302,440x
Earnings Revenue Estimate Growth	15.63x
Operating Income	$3.5B
Operating Income Growth	31.04
Operating Income Growth Q	30.74
Operating Income Growth3 Y	27.88
Operating Income Growth5 Y	16.41
Operating margin	31.28
Price target	$477
Price Target Change	$25.99
Price Target Change Top	$21.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	344,170,843%
Float Percent	97.42%
Shares Insiders	0.48%
Shares Institutions	85.73%
Shares Out	353,278,038
Shares Qo Q	-0.69%
Shares Yo Y	-1.11%
Short Float	1.95%
Short Ratio	2.42
Short Shares	1.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.4B
Adjusted OCF	2,880,200,000
Average Volume	4,268,303.05x
Bv Per Share	51.34
CAPEX	$-483.8M
Ch10y	391.7
Ch15y	850.8
Ch1m	-12.48
Ch1w	7.21
Ch1y	-20.09
Ch20y	3,325
Ch3m	-16.14
Ch3y	22.47
Ch5y	10.33
Ch6m	-22.4
Change	1.36%
Change From Open	1.14
Close	373.7
Days Gap	0.22
Depreciation Amortization	729,600,000
Dollar Volume	934,013,255.3
Earnings Date	2026-07-16
Earnings Time	amc
EBIT	$3.5B
EBITDA	$4.2B
EPS	$8.72
F Score	6
FCF	$3.2B
FCF EV Yield	2.51x
FCF Per Share	$9.12
Financing CF	-3,622,100,000
Fiscal Year End	December
Founded	1,995
Goodwill	580,600,000
Graham Number	100.36489
Graham Upside	-73.51
Income Tax	$647.9M
Investing CF	-749,500,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-16
Last Report Date	2026-06-30
Last Split Date	2021-10-05
Last Split Type	Forward
Last10k Filing Date	2026-02-03
Lynch Fair Value	$123
Lynch Upside	-67.53
Ma150	454.4
Ma150ch	-16.63%
Ma20	364.3
Ma20ch	3.98%
Net CF	-640,800,000
Next Earnings Date	2026-10-20
Open	374.6
Optionable	Yes
P FCF Ratio	41.53
P FCF Ratio SBC	55.84
P OCF Ratio	36.11
P OCF Ratio SBC	46.46
Position In Range	85.01
Post Close	378.8
Postmarket Change Percent	0.03
Postmarket Price	$379
Ppne	5,551,500,000
Pre Close	373.7
Price Date	2026-08-07
Price EBITDA	$31.52
Ptbv Ratio	7.7
Relative Volume	0.58x
Revenue	11,034,400,000x
SBC By Revenue	7.49x
Share Based Comp	826,200,000
Tax By Revenue	5.87x
Tax Rate	17.02%
Tr20y	3,325.05%
Tr6m	-22.4%
Us State	California
Views	167
Volume	2,465,651
Z Score	42.45

Frequently asked questions

About this ISRG report

What is the latest published ISRG stock rating?

Intuitive Surgical Inc. is shown with sell in the latest published report, analyzed 2026-05-09. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ISRG analysis?

The full latest published report, analyzed 2026-05-09, lives at /stocks/ISRG/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for ISRG?

The latest published report analyzed 2026-05-09 frames ISRG around USD 176 to USD 337. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the ISRG page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-09). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Intuitive Surgical Inc. (ISRG)

Coverage state: Latest published research available

Generate a fresh ISRG analysis

Our latest published analysis: ISRG rated Sell

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ISRG

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All ISRG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ISRG

Frequently asked questions